This first week of July GCT is pleased to announce a new deal to execute a non-interventional study in the area of preterm birth prevention. The research is to be performed throughout 39 clinical centers across Czech Republic, Hungary, Russia and Ukraine.

The subjects are infants born to mothers who participated in the Phase III clinical trial of a drug against pre-term labor, which is also regionally managed by GCT.